We are delighted to announce George Frodsham, Founder and CEO of MediSieve in London as our Overall Champion decided by our 3 brilliant Judges at Hays UK & Ireland, Hays Spain and Sifted MediSieve is a biotech company, developing “Magnetic Blood Filtration” (MBF), a combination of a device and a therapeutic platform for treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. From sepsis to malaria to leukaemia and viral infections, such as COVID-19, MediSieve has the ambition of providing hospitals with a tool to tackle some of mankind’s most serious diseases. The company’s first product is for the removal of IL-6 to treat patients experiencing hyper inflammation, including those suffering from sepsis, cytokine storms and COVID-19. The technology is pre-clinical, and MediSieve is currently raising £3.7M to support pivotal clinical trials. The company has recently been awarded a £1.55M grant from UKRI to trial the technology in COVID-19.